DILTIAZEM HYDROCHLORIDE FORMULATION COMPRISING BEADS WITH IMMEDIATE, INTERMEDIATE, AND DELAYED RELEASE DISSOLUTION PROFILES

• 1. 一种复方盐酸二甲双胍盐酸吡格列酮缓释微丸制剂的组配方法及制备工艺 [P] . 中国专利： CN103446063B . 2016.01.20
• 2. 一种复方盐酸二甲双胍盐酸吡格列酮缓释微丸制剂的组配方法及制备工艺 [P] . 中国专利： CN103446063A . 2013-12-18
• 3. Oral diltiazem hydrochloride dosage forms - for admin. once a day, contg. fast- and delayed-release components [P] . 德国专利： DE3922167A1 . 1991-01-17

  机译： 口服地尔硫卓盐酸盐剂型-给药每天一次，续。快释和延迟释放成分

• 4. PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION WITH CONTROLLED DISSOLUTION RATE COMPRISING SUSTAINED-RELEASE PELLETS CONTAINING TAMSULOSIN HYDROCHLORIDE [P] . 美国专利： US2019167612A1 . 2019-06-06

  机译： 包含盐酸坦莫司汀的缓释药丸的溶出度受控的药物配制剂

• 5. A pharmaceutical formulation for oral administration with controlled dissolution rate comprising sustained-release pellets containing tamsulosin hydrochloride [P] . 韩国专利： KR20180018450A . 2018-02-21

  机译： 具有受控溶出度的口服给药药物制剂，其包含含有坦洛新盐酸盐的缓释微丸

• 1. Design and in vitro evaluation of controlled release alginate beads of diltiazem hydrochloride [J] . D.Nagasamy Venkatesh, A.Kalaivani, Kritika D.Kalro, 亚太热带医药杂志（英文版） . 2009,第004期
• 2. Monitoring the hydrolyzation of aspirin during the dissolution testing for aspirin delayed-release tablets with a fiber-optic dissolution system [J] . Yan Wang, Ping-Ping Xu, Xin-Xia Li, 西安医科大学学报(英文版) . 2012,第005期
• 3. Monitoring the hydrolyzation of aspirin during the dissolution testing for aspirin delayed-release tablets with a fiber-optic dissolution system [J] . Yan Wang, Ping-Ping Xu, Xin-Xia Li, 药物分析学报（英文） . 2012,第005期
• 4. Validated gradient stability indicating HPLC method for determining Diltiazem Hydrochloride and related substances in bulk drug and novel tablet formulation [J] . Vivekanand A. Chatpalliwara, Pawan K. Porwal, Neeraj Upmanyu 药物分析学报（英文） . 2012,第003期
• 5. GUM GHATTI: A NEW RELEASE MODIFIER FOR ZERO-ORDER RELEASE IN 3- LAYERED TABLETS OF DILTIAZEM HYDROCHLORIDE [C] . Joshi.M., Patel N., Deshmukh.A., Annual meeting exposition of the Controlled Release Society . 2010
• 6. 1. Development of hot-melt pan-coating, application to sustained-release capsules and tamper resistant-coating. 2. Formulation of verapamil hydrogen chloride and diltiazem hydrogen chloride semisolid matrix capsules. 3. Novel sustained release tablet of glipizide: Compression of coated drug beads, formulation, dissolution, and convolution. 4. Verapamil sustained release: New formulation and convolution. [D] . Nguyen, Chien Ngoc. 2006
• 7. Statistical Comparison of Dissolution Profiles to Predict the Bioequivalence of Extended Release Formulations [O] . J. D. Gomez-Mantilla, U. F. Schaefer, V. G. Casabo, 2014
• 8. Formulation and Development of Diltiazem Hydrochloride Sustained Release Alginate Beads by Ionotropic External Gelation Technique [O] . Mokale Vinod, Naik Jitendra, Khairnar Gayatri, 2013

• 1. Quality of compounded topical 2 diltiazem hydrochloride formulations for anal fissure [J] . Monil Shah ,Laura Sandler ,Vishwas Rai . 世界胃肠病学杂志：英文版 . 2013,第34期
• 2. 采用多条溶出曲线评价国产盐酸普罗帕酮片的内在质量 [C] . 杨林 ,侯小梅 ,龚士学 . 第3届全国药品质量分析论坛 . 2012
• 3. 席夫碱基咪唑啉和噻二唑衍生物对钢在盐酸介质中和铜在碳酸氢钠介质中缓蚀性能的研究 [A] . 朱丽琴 . 2006